Tech Company Financing Transactions
PhosImmune Funding Round
PhosImmune closed a investment round on 8/13/2014. Investors included CIT GAP Fund.
Transaction Overview
Company Name
Announced On
8/13/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand and continue its current trials, and to develop an additional PTA-based immunotherapy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Forbes Rd.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
PhosImmune is a clinical-stage biotechnology company developing therapeutic cancer vaccines. PhosImmune controls a library of unique, aberrantly phosphorylated tumor antigens (PTAs) that are directly implicated in metastasis, meeting a pressing need for high quality tumor antigens for use in new and more effective cancer vaccines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Garo Armen
Chief Financial Officer
Evan Ballantyne
Chief Technical Officer
Alex Duncan
VP - Bus. Development
Ozer Baysal
VP - Human Resources
John Cerio
Browse more venture capital transactions:
Prev: 8/13/2014: Gett venture capital transaction
Next: 8/13/2014: Lookout venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs